1] Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA. [2] Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Nat Neurosci. 2013 Oct;16(10):1373-82. doi: 10.1038/nn.3510. Epub 2013 Sep 1.
Like all cancers, brain tumors require a continuous source of energy and molecular resources for new cell production. In normal brain, glucose is an essential neuronal fuel, but the blood-brain barrier limits its delivery. We now report that nutrient restriction contributes to tumor progression by enriching for brain tumor initiating cells (BTICs) owing to preferential BTIC survival and to adaptation of non-BTICs through acquisition of BTIC features. BTICs outcompete for glucose uptake by co-opting the high affinity neuronal glucose transporter, type 3 (Glut3, SLC2A3). BTICs preferentially express Glut3, and targeting Glut3 inhibits BTIC growth and tumorigenic potential. Glut3, but not Glut1, correlates with poor survival in brain tumors and other cancers; thus, tumor initiating cells may extract nutrients with high affinity. As altered metabolism represents a cancer hallmark, metabolic reprogramming may maintain the tumor hierarchy and portend poor prognosis.
与所有癌症一样,脑肿瘤的新细胞生成需要持续的能量和分子资源。在正常大脑中,葡萄糖是神经元的重要燃料,但血脑屏障限制了其输送。我们现在报告说,营养限制通过富集脑肿瘤起始细胞(BTIC)促进肿瘤进展,这是由于 BTIC 的优先存活以及非 BTIC 通过获得 BTIC 特征而适应的结果。BTIC 通过协同利用高亲和力神经元葡萄糖转运蛋白 3(Glut3,SLC2A3)来竞争摄取葡萄糖。BTIC 优先表达 Glut3,靶向 Glut3 可抑制 BTIC 生长和致瘤潜能。Glut3 而不是 Glut1 与脑肿瘤和其他癌症的不良预后相关;因此,起始肿瘤细胞可能会以高亲和力提取营养物质。由于代谢改变是癌症的一个标志,代谢重编程可能维持肿瘤层次结构并预示预后不良。